Yumanity Therapeutics

Yumanity Therapeutics is a biotechnology company dedicated to the research and development of drugs for neurodegenerative diseases, with the goal of developing new treatments for Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). The Lindquist Lab has utilized this technology to screen over 500,000 compounds and has identified at least one molecular target and lead compound for the treatment of Parkinson's disease.